Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Herpes Zoster Infection Complicates Cataract Surgery; The Center for the Biology of Chronic Disease Reviews a Study
  • USA - English


News provided by

CBCD

Mar 20, 2015, 00:00 ET

Share this article

Share toX

Share this article

Share toX


Rochester, NY (PRWEB) March 20, 2015 -- “Infected with the varicella zoster virus (VZV), which causes shingles? The Center for the Biology of Chronic Disease (CBCD), which tested the formula of Novirin in two post-marketing clinical studies, recommends taking this natural antiviral supplement against the latent virus.” – Greg Bennett, CBCD

Visual recovery after cataract surgery in HZO … might be hindered by the inherent pathology associated with HZO.- Dr. He. (1)

Post this

Patients who have had a herpes zoster outbreak that affects the eyes (a condition known as herpes zoster ophthalmicus, or HZO) may have a harder, and longer, recovery time following surgery to remove cataracts. In a new study, Dr. He and colleagues wrote that “visual recovery after cataract surgery in HZO … might be hindered by the inherent pathology associated with HZO.” (1) Dr. He is from the Beijing Ophthalmic and Visual Science Key Laboratory, in China.

The CBCD points out that “Herpes Zoster (HZ), commonly called shingles, is a distinctive syndrome caused by reactivation of varicella zoster virus (VZV). This reactivation happens whenever immunity to VZV declines as a result of aging or immunosuppression (a damaged immune system). Herpes Zoster will happen at any age yet commonly affects the elderly population.” (See Mayo Clinic Proceedings, from March 2009) (2) The CBCD points out that when the immune system is damaged, a latent virus, such as VZV, can increase in number, causing shingles and resulting diseases.

The varicella zoster virus (VZV) is a herpes virus, which causes both chickenpox and shingles. The virus is also called herpes zoster. The VZV can cause vision loss if it reactivates and attacks the eye. This condition is known as herpes zoster ophthalmicus. “Symptoms and signs, which may be intense, include dermatomal forehead rash and painful inflammation of all the tissues of the anterior and, rarely, posterior structures of the eye.” (See the Merck Manual, last reviewed September 2014. (3) Additionally, in up to 31% of those with HZO, the virus causes paralysis in muscles outside of the eye. Dr. Chaker and colleagues wrote in a another study that “HZO may cause extraocular muscle palsies of the third, fourth, and sixth cranial nerves in 7-31% of patients … the extraocular muscle palsies (muscular paralysis) usually appear 2-4 weeks after the rash, but sometimes occurs simultaneously with the rash or more than 4 weeks later.” (See Current Neurology and Neuroscience Reports, published online in advance of April 2015) (4) Dr. Chaker and colleagues are part of the Faculty of Medicine of Tunis at the University of El Manar in Tunisia.

Click to learn more about latent viruses.

The CDC notes that “Nearly 1 out of every 3 people in the United States will develop shingles in their lifetime. Anyone who has had chickenpox or received chickenpox vaccine in the past may develop shingles.” (See CDC, last updated May 1, 2014) (5)

The CBCD recommends that people who have had chickenpox in the past take Novirin. The formula of this natural antiviral product was tested by Hanan Polansky and Edan Itzkovitz from the CBCD in two clinical studies that followed FDA guidelines. The studies showed that the Novirin formula is effective against herpes viruses (like VZV), and other viruses. The clinical studies were published in the peer reviewed, medical journal Pharmacology & Pharmacy, the first, in a special edition on Advances in Antiviral Drugs. Study authors wrote that, “individuals infected with a (latent virus) … reported a safe decrease in their symptoms following treatment with (the Novirin formula).” (6) The study authors also wrote that, “we observed a statistically significant decrease in the severity, duration, and frequency of symptoms.” (6)

Novirin can be ordered on the product website here: http://www.novirin.com

Novirin is a natural antiviral dietary supplements. Its formula contains five natural ingredients: Selenium, Camellia Sinesis Extract, Quercetin, Cinnamomum Extract, and Licorice Extract. The first ingredient is a trace element, and the other four are plant extracts. Each ingredient and its dose was chosen through a scientific approach. Scientists at polyDNA, the company that invented and patented the formula, scanned thousands of scientific and medical papers published in various medical and scientific journals, and identified the safest and most effective natural ingredients against latent viruses.

To date, Novirin is the only natural antiviral product on the market with published clinical studies that support its claims.

In addition to complicating cataract sugery, herpes zoster can also cause the following conditions in the eye: “conjunctivitis (inflammation of the conjunctiva, the outermost layer of the eye, and the inner surface of the eyelids), keratitis (inflammation of the eye’s cornea), episcleritis (inflammation of the thin layer of tissue that lies between the conjunctiva and the connective tissue layer that forms the white of the eye), scleritis (a serious inflammatory disease that affects the white outer coating of the eye), uveitis (inflammation of the uvea), secondary glaucoma (a condition characterized by fluid pressure in the eye that can lead to blindness), cataract (a clouding of the lens inside the eye which leads to a decrease in vision), and retinal necrosis (an aggressive, necrotizing inflammation of the eye's retina).” (3)

Are there effective treatments against the VZV?

WebMD says that, “several antiviral medicines-acyclovir, valacyclovir, and famciclovir-are available to treat shingles. These medicines will help shorten the length and severity of the illness. But to be effective, they must be started as soon as possible after the rash appears. Thus, people who have or think they might have shingles should call their healthcare provider as soon as possible to discuss treatment options. Analgesics (pain medicine) may help relieve the pain caused by shingles. Wet compresses, calamine lotion, and colloidal oatmeal baths may help relieve some of the itching.” (See WebMD, last updated May 1, 2014) (7) The CBCD reminds the public that there is also the safe and effective anti-VZV remedy, Novirin.

“The CBCD recommends that people infected with a latent virus like VZV take Novirin.” - Greg Bennett, CBCD

Click to learn more about Novirin: http://www.novirin.com.

References:

(1)    He Y1, de Melo Franco R1, Kron-Gray MM1, Musch DC1, Soong HK2. "Outcomes of cataract surgery in eyes with previous herpes zoster ophthalmicus." J Cataract Refract Surg. 2015 Mar 12.
http://www.ncbi.nlm.nih.gov/pubmed/25771135

(2) Priya Sampathkumar, MD, Lisa A. Drage, MD, and David P. Martin, MD, PhD Herpes Zoster (Shingles) and Postherpetic Neuralgia. Mayo Clinic Proceedings. March 2009.
ncbi.nlm.nih.gov/pmc/articles/PMC2664599/

(3) The Merck Manual - Herpes Zoster Ophthalmicus. Last full review/revision September 2014 by Melvin I. Roat, MD, FACS
http://www.merckmanuals.com/professional/eye_disorders/corneal_disorders/herpes_zoster_ophthalmicus.html

(4) Chaker N, Bouladi M, Chebil A, Jemmeli M, Mghaieth F, El Matri L. Herpes zoster ophthalmicus associated with abducens palsy. J Neurosci Rural Pract. 2014 Apr;5(2):180-2. http://www.ncbi.nlm.nih.gov/pubmed/24966563

(5)    CDC – Shingles (Herpes Zoster). Last updated May 1, 2014.
cdc.gov/shingles/about/symptoms.html

(6)    Polansky H, Itzkovitz E. Gene-Eden-VIR Is Antiviral: Results of a Post Marketing Clinical Study. Pharmacology & Pharmacy, 2013, 4, 1-8
http://www.scirp.org/journal/PaperInformation.aspx?PaperID=36101#.U-c7EeOSz90

(7)    WebMD - Shingles Health Center - Topic Overview. Last updated December 18, 2012. webmd.com/skin-problems-and-treatments/shingles/shingles-topic-overview

Greg Bennett, CBCD, http://gene-eden-kill-virus.com/, +1 5852509999, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.